Anti-Human CD51+CD61 Therapeutic Antibody (Etaracizumab)
Recombinant monoclonal antibody to Human CD51+CD61. Etaracizumab (also known as etaratuzumab, MEDI-522, trade name Abegrin) is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-025 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD51+CD61 |
| Species Reactivity | Human |
| Type | IgG1 |
| Applications | IP, IF, FuncS, FC, Neut, ELISA, ICC, WB, Inhib |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |